Bel Fuse Inc. (NASDAQ:BELFA – Get Free Report) shares saw unusually-strong trading volume on Friday . Approximately 22,610 shares were traded during mid-day trading, an increase of 148% from the previous session’s volume of 9,119 shares.The stock last traded at $79.75 and had previously closed at $80.70.
Bel Fuse Stock Performance
The stock has a market cap of $1.02 billion, a price-to-earnings ratio of 14.30 and a beta of 1.35. The company has a quick ratio of 2.70, a current ratio of 4.21 and a debt-to-equity ratio of 0.17. The company’s 50-day simple moving average is $76.12 and its 200-day simple moving average is $69.92.
Bel Fuse (NASDAQ:BELFA – Get Free Report) last issued its earnings results on Thursday, April 25th. The scientific and technical instruments company reported $1.19 EPS for the quarter. Bel Fuse had a return on equity of 24.29% and a net margin of 12.62%. The business had revenue of $128.09 million during the quarter.
Bel Fuse Dividend Announcement
Hedge Funds Weigh In On Bel Fuse
An institutional investor recently bought a new position in Bel Fuse stock. Brown Advisory Inc. acquired a new stake in shares of Bel Fuse Inc. (NASDAQ:BELFA – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 37,774 shares of the scientific and technical instruments company’s stock, valued at approximately $2,442,000. Brown Advisory Inc. owned 0.30% of Bel Fuse at the end of the most recent quarter. Institutional investors and hedge funds own 6.01% of the company’s stock.
Bel Fuse Company Profile
Bel Fuse Inc designs, manufactures, markets, and sells products that power, protect, and connect electronic circuits. The company's products are used in the networking, telecommunications, computing, general industrial, high-speed data transmission, military, commercial aerospace, transportation, and e-Mobility industries.
Featured Articles
- Five stocks we like better than Bel Fuse
- Health Care Stocks Explained: Why You Might Want to Invest
- McDonald’s Stock: Balancing Value and Innovation
- Ride Out The Recession With These Dividend Kings
- MarketBeat Week in Review – 6/17 – 6/21
- Roth IRA Calculator: Calculate Your Potential Returns
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Bel Fuse Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bel Fuse and related companies with MarketBeat.com's FREE daily email newsletter.